Regencell Bioscience’s investigational liquid-formula RGC-COV19TM shows effectiveness through its enrolled patients

Regencell Bioscience’s investigational liquid-formula RGC-COV19TM shows effectiveness through its enrolled patients

• 36 out of 37 COVID-19 patients treated in the trial, representing approximately 97.3% of the patients, reported they had all symptoms eliminated within the 6-day treatment period save for loss or reduced sense of taste and smell (“Sensory Dysfunction”) and occasional cough. The highest number of different symptoms reported for any one individual was 14.

Berita Populer


ASEANFLAG

Kategori Berita